Striking Merger: Coeptis Therapeutics and Z Squared Unite for Domination in Dogecoin Mining
Biotechnology Company's Stock Dives Due to Proposed Transition to Dogecoin Mining Operations
Get a load of this electrifying announcement! Biopharmaceutical powerhouse, Coeptis Therapeutics, is joining forces with Dogecoin mining gurus, Z Squared Inc. The ultimate goal? To step up as the largest publicly-traded Dogecoin miner in the U.S. Curious about how it all goes down? Let's dig a little deeper.
Z Squared's CEO, Dave Halabu, is the man with the plan. In a classic fist-pump moment, he proclaimed, "We're gunning for it! We're thrilled to move forward with our dream of becoming the largest DOGE-focused entity in the open market."
As for the matching of these two corporate titans, the boardrooms of both companies have given it the green light, but closing conditions and regulatory and shareholder approval are still on the table.
The freshly merged beast will have Z Squared operating under Coeptis' wing, thanks to the latter's 9,000 Dogecoin mining machines. Exciting things are brewing, and the new entity is aiming to bring retail and institutional investors alike into the fiery, Doge-filled world of public markets.
Meanwhile, Dave Mehalick, the current Coeptis President and CEO, is looking out for number one. He'll be spinning off the biopharmaceutical operations of Coeptis to focus on its groundbreaking work in cancer, autoimmune, and infectious diseases. Onward and upward!
But how's the stock market feeling about this marriage of convenience? Well, it seems shareholders aren't loving this new relationship as much as the companies themselves, with shares of Coeptis taking a 40% nosedive on the day of the announcement. Still, it's a drop in the ocean compared to Coeptis' all-time high.
And speaking of Dogecoin, the coin has been enjoying a solid week, climbing 16% and currently trading above $0.18. Could this be the perfect time for a stake in the game?
These two companies aren't the only ones dabbling in Dogecoin. Neptune Digital Assets and Spirit Blockchain Capital are also getting their paws on the prize, making Coeptis' move a strategic one that could cement its place as a top Doge miner.
Stay tuned for more updates as cryptocurrencies continue to shake up the stock market. It's a wild ride, but someone's gotta navigate it, right?
[1] Coeptis Therapeutics to Merge with Z Squared Inc. (press release), March 1, 2023.[2] "What is Dogecoin?" Investopedia, accessed March 1, 2023.[3] Ruan, Melody. "U.S. Crypto Mining Operations Gain Momentum," Law360, February 28, 2023.[4] Silber, Aaron. "Coeptis Therapeutics to Merge with Z Squared," Decrypt, March 1, 2023.[5] Hayward, Andrew. "Coeptis to Merge with Z Squared, Aiming to be the Largest Publicly Traded DOGE Miner in the U.S.," Decrypt, March 1, 2023.
- The merger between Coeptis Therapeutics and Z Squared Inc aims to position them as the largest publicly-traded Dogecoin miner in the U.S.
- As part of the merger, Z Squared will be operating under Coeptis' wing, leveraging Coeptis' 9,000 Dogecoin mining machines.
- Coeptis is planning to spin off its biopharmaceutical operations to focus on its work in cancer, autoimmune, and infectious diseases.
- Dave Mehalick, the current Coeptis President and CEO, will lead the biopharmaceutical spin-off, while Dave Halabu, Z Squared's CEO, will focus on Dogecoin mining.
- The newly merged entity aims to attract retail and institutional investors alike to the Dogecoin market.
- Following the merger announcement, shares of Coeptis took a 40% nosedive, but thecoin itself has been experiencing a 16% climb and is currently trading above $0.18.
- Other companies like Neptune Digital Assets and Spirit Blockchain Capital are also investing in Dogecoin, making Coeptis' move a strategic one to secure its place as a top Doge miner in the competitive cryptocurrency market.
